{
  "issues": [
    "Renal tool summary incorrectly states “Missing BMI or creatinine” even though creatinine is present; the tool also notes missing lab timestamps, which limits auditability of the renal risk assessment.",
    "Renal tool summary lists “No lab timestamps provided” despite timestamps being present for each lab check; this inconsistency may reduce confidence in the tool’s output.",
    "While the renal risk is low (eGFR 135 mL/min/1.73 m²), the patient’s severe hypotension (MAP ≈ 49 mmHg) is a significant hemodynamic risk that the renal tool does not address.",
    "Agent 2 recommends both a broad trauma CT (Chest/Abdomen/Pelvis) and a dedicated pulmonary CTA; using both may be redundant or expose the patient to excess contrast if the trauma protocol already includes pulmonary arterial phase imaging.",
    "No explicit recommendation for post‑contrast renal monitoring (e.g., repeat creatinine/BUN at 24–48 h) was provided."
  ],
  "recommendations": [
    "Proceed with a trauma‑focused CT protocol (e.g., CT_TRAUMA_CHEST_ABD_PELVIS) that includes a dedicated thoracic aorta CTA sequence, as this is the gold‑standard for evaluating aortic injury.",
    "If the trauma protocol does not adequately cover the pulmonary arterial phase, add a targeted pulmonary angiography acquisition rather than a full separate CT pulmonary embolism (CTPA) study to avoid excess contrast volume.",
    "Administer isotonic IV fluids (e.g., 1 L normal saline or balanced solution) before contrast administration to improve intravascular volume and mitigate risk of contrast‑induced nephropathy in the context of severe hypotension.",
    "Use a low‑contrast‑volume strategy (e.g., split‑bolus or reduced total volume) while ensuring adequate arterial opacification for aortic and pulmonary arterial assessment.",
    "Continuously monitor hemodynamics (MAP, heart rate, urine output) during and after contrast administration; be prepared to intervene with vasopressors or additional fluid boluses if MAP remains <60 mmHg.",
    "Obtain baseline serum creatinine and BUN prior to contrast (already available) and repeat them at 24–48 h post‑contrast to detect any acute kidney injury early.",
    "If the patient’s hemodynamic status deteriorates or if renal function worsens, consider alternative non‑contrast imaging (e.g., trans‑esophageal echocardiography for aortic injury) or defer contrast‑based imaging until stabilized.",
    "Document the decision‑making process, including the rationale for contrast use, the volume and type of contrast, hydration protocol, and the plan for post‑contrast renal monitoring."
  ],
  "confidence": 0.38,
  "agent2_confidence": null,
  "timestamp": "2025-08-15T15:32:57.340039Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-15T15:32:53.963390Z",
          "priority": "critical",
          "value": 135.1,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-15T15:32:53.963397Z",
          "priority": "critical",
          "value": 0.5,
          "status": "pass",
          "reason": "Creatinine within normal range."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-15T15:32:53.963400Z",
          "priority": "important",
          "value": 16.0,
          "status": "pass",
          "reason": "BUN/Cr ratio normal."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-15T15:32:53.963406Z",
          "priority": "important",
          "value": 3.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "pass",
        "reasons": [
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.92
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-15T15:32:53.963422Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool summary incorrectly states “Missing BMI or creatinine” even though creatinine is present; the tool also notes missing lab timestamps, which limits auditability of the renal risk assessment.\",\n    \"Renal tool summary lists “No lab timestamps provided” despite timestamps being present for each lab check; this inconsistency may reduce confidence in the tool’s output.\",\n    \"While the renal risk is low (eGFR 135 mL/min/1.73 m²), the patient’s severe hypotension (MAP ≈ 49 mmHg) is a significant hemodynamic risk that the renal tool does not address.\",\n    \"Agent 2 recommends both a broad trauma CT (Chest/Abdomen/Pelvis) and a dedicated pulmonary CTA; using both may be redundant or expose the patient to excess contrast if the trauma protocol already includes pulmonary arterial phase imaging.\",\n    \"No explicit recommendation for post‑contrast renal monitoring (e.g., repeat creatinine/BUN at 24–48 h) was provided.\"\n  ],\n  \"recommendations\": [\n    \"Proceed with a trauma‑focused CT protocol (e.g., CT_TRAUMA_CHEST_ABD_PELVIS) that includes a dedicated thoracic aorta CTA sequence, as this is the gold‑standard for evaluating aortic injury.\",\n    \"If the trauma protocol does not adequately cover the pulmonary arterial phase, add a targeted pulmonary angiography acquisition rather than a full separate CT pulmonary embolism (CTPA) study to avoid excess contrast volume.\",\n    \"Administer isotonic IV fluids (e.g., 1 L normal saline or balanced solution) before contrast administration to improve intravascular volume and mitigate risk of contrast‑induced nephropathy in the context of severe hypotension.\",\n    \"Use a low‑contrast‑volume strategy (e.g., split‑bolus or reduced total volume) while ensuring adequate arterial opacification for aortic and pulmonary arterial assessment.\",\n    \"Continuously monitor hemodynamics (MAP, heart rate, urine output) during and after contrast administration; be prepared to intervene with vasopressors or additional fluid boluses if MAP remains <60 mmHg.\",\n    \"Obtain baseline serum creatinine and BUN prior to contrast (already available) and repeat them at 24–48 h post‑contrast to detect any acute kidney injury early.\",\n    \"If the patient’s hemodynamic status deteriorates or if renal function worsens, consider alternative non‑contrast imaging (e.g., trans‑esophageal echocardiography for aortic injury) or defer contrast‑based imaging until stabilized.\",\n    \"Document the decision‑making process, including the rationale for contrast use, the volume and type of contrast, hydration protocol, and the plan for post‑contrast renal monitoring.\"\n  ],\n  \"confidence\": 0.88\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool summary incorrectly states “Missing BMI or creatinine” even though creatinine is present; the tool also notes missing lab timestamps, which limits auditability of the renal risk assessment.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool summary lists “No lab timestamps provided” despite timestamps being present for each lab check; this inconsistency may reduce confidence in the tool’s output.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "While the renal risk is low (eGFR 135 mL/min/1.73 m²), the patient’s severe hypotension (MAP ≈ 49 mmHg) is a significant hemodynamic risk that the renal tool does not address.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '35'"
      },
      {
        "text": "Agent 2 recommends both a broad trauma CT (Chest/Abdomen/Pelvis) and a dedicated pulmonary CTA; using both may be redundant or expose the patient to excess contrast if the trauma protocol already includes pulmonary arterial phase imaging.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "No explicit recommendation for post‑contrast renal monitoring (e.g., repeat creatinine/BUN at 24–48 h) was provided.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Proceed with a trauma‑focused CT protocol (e.g., CT_TRAUMA_CHEST_ABD_PELVIS) that includes a dedicated thoracic aorta CTA sequence, as this is the gold‑standard for evaluating aortic injury.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If the trauma protocol does not adequately cover the pulmonary arterial phase, add a targeted pulmonary angiography acquisition rather than a full separate CT pulmonary embolism (CTPA) study to avoid excess contrast volume.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Administer isotonic IV fluids (e.g., 1 L normal saline or balanced solution) before contrast administration to improve intravascular volume and mitigate risk of contrast‑induced nephropathy in the context of severe hypotension.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Use a low‑contrast‑volume strategy (e.g., split‑bolus or reduced total volume) while ensuring adequate arterial opacification for aortic and pulmonary arterial assessment.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Continuously monitor hemodynamics (MAP, heart rate, urine output) during and after contrast administration; be prepared to intervene with vasopressors or additional fluid boluses if MAP remains <60 mmHg.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Obtain baseline serum creatinine and BUN prior to contrast (already available) and repeat them at 24–48 h post‑contrast to detect any acute kidney injury early.",
        "type": "recommendation",
        "classification": "contradicted",
        "rationale": "creatinine 24.0 contradicts known 0.5"
      },
      {
        "text": "If the patient’s hemodynamic status deteriorates or if renal function worsens, consider alternative non‑contrast imaging (e.g., trans‑esophageal echocardiography for aortic injury) or defer contrast‑based imaging until stabilized.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document the decision‑making process, including the rationale for contrast use, the volume and type of contrast, hydration protocol, and the plan for post‑contrast renal monitoring.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 12,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 0,
      "contradicted": 1
    },
    "hallucination_score": 0.077,
    "recommendation": {
      "force_revision": true,
      "confidence_reduction": 0.5
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 10014729.0,
        "hadm_id": 28889419.0,
        "stay_id": 33558396.0,
        "age": 21.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 2.47,
        "los_icu_days": 2.47,
        "creatinine_mg_dl": 0.5,
        "bun_mg_dl": 8.0,
        "glucose_mg_dl": 76.0,
        "hemoglobin_g_dl": 10.3,
        "hematocrit_pct": 29.9,
        "platelet_count": 229.0,
        "wbc_count": 6.9,
        "sodium_meq_l": 137.0,
        "potassium_mmol_l": 3.6,
        "chloride_meq_l": 97.0,
        "bicarbonate_meq_l": 25.0,
        "egfr_ckd_epi": 135.1,
        "ckd_stage": 1.0,
        "bun_creatinine_ratio": 16.0,
        "heart_rate_bpm": 107.0,
        "systolic_bp_mmhg": 78.0,
        "diastolic_bp_mmhg": 35.0,
        "map_mmhg": 49.3,
        "pulse_pressure_mmhg": 43.0,
        "temperature_f": 99.1,
        "spo2_pct": 98.0,
        "respiratory_rate": 18.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "137.0",
        "creatinine within normal range.",
        "white - other european",
        "43.0",
        "bun_creatinine_ratio",
        "0.95",
        "8.0",
        "low renal risk for contrast.",
        "stage 1 (normal)",
        "0"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool summary incorrectly states “Missing BMI or creatinine” even though creatinine is present; the tool also notes missing lab timestamps, which limits auditability of the renal risk assessment.",
      "Renal tool summary lists “No lab timestamps provided” despite timestamps being present for each lab check; this inconsistency may reduce confidence in the tool’s output.",
      "While the renal risk is low (eGFR 135 mL/min/1.73 m²), the patient’s severe hypotension (MAP ≈ 49 mmHg) is a significant hemodynamic risk that the renal tool does not address.",
      "Agent 2 recommends both a broad trauma CT (Chest/Abdomen/Pelvis) and a dedicated pulmonary CTA; using both may be redundant or expose the patient to excess contrast if the trauma protocol already includes pulmonary arterial phase imaging.",
      "No explicit recommendation for post‑contrast renal monitoring (e.g., repeat creatinine/BUN at 24–48 h) was provided."
    ],
    "recommendations": [
      "Proceed with a trauma‑focused CT protocol (e.g., CT_TRAUMA_CHEST_ABD_PELVIS) that includes a dedicated thoracic aorta CTA sequence, as this is the gold‑standard for evaluating aortic injury.",
      "If the trauma protocol does not adequately cover the pulmonary arterial phase, add a targeted pulmonary angiography acquisition rather than a full separate CT pulmonary embolism (CTPA) study to avoid excess contrast volume.",
      "Administer isotonic IV fluids (e.g., 1 L normal saline or balanced solution) before contrast administration to improve intravascular volume and mitigate risk of contrast‑induced nephropathy in the context of severe hypotension.",
      "Use a low‑contrast‑volume strategy (e.g., split‑bolus or reduced total volume) while ensuring adequate arterial opacification for aortic and pulmonary arterial assessment.",
      "Continuously monitor hemodynamics (MAP, heart rate, urine output) during and after contrast administration; be prepared to intervene with vasopressors or additional fluid boluses if MAP remains <60 mmHg.",
      "Obtain baseline serum creatinine and BUN prior to contrast (already available) and repeat them at 24–48 h post‑contrast to detect any acute kidney injury early.",
      "If the patient’s hemodynamic status deteriorates or if renal function worsens, consider alternative non‑contrast imaging (e.g., trans‑esophageal echocardiography for aortic injury) or defer contrast‑based imaging until stabilized.",
      "Document the decision‑making process, including the rationale for contrast use, the volume and type of contrast, hydration protocol, and the plan for post‑contrast renal monitoring."
    ],
    "confidence": 0.38
  }
}